heading
What do we do?
The Consortium collaborates across communities to create registries, connect individuals with curated cancer clinical trials and studies, and generate new funding to promote diverse and equitable participation in health research.
Join CORe Consortium
Please reach out to us if you would be interested in learning more about CORe Consortium.
heading
Douglas B. Flora, MD, LSSBB
Executive Medical Director, Oncology Services, St. Elizabeth Healthcare | American Cancer Society Board | ACCC Exec Board
Dr. Flora serves as the Executive Medical Director of Oncology Services at St. Elizabeth and was recently named The Robert and Dell Ann Sathe Endowed Chair in Oncology. Dr. Flora was born and raised in Cincinnati, graduating from The Ohio State University College of Medicine in 1999, and has been named a Cincinnati Magazine Top Doctor in Hematology and Oncology for the past 15 consecutive years. He is a Board Member of Kentucky Society of Clinical Oncology, The American Cancer Society Regional Board, and The Andy and Jordan Dalton Foundation.
heading
Praduman Jain (PJ)
PI, NIH All of Us Research Program | PI, NIH AIM-AHEAD program | PI, NIH RADx TECH and RADx UP | Founder and CEO of Vibrent Health
Praduman Jain (PJ) is the Founder and CEO of Vibrent Health and the contact PI of the Participant Technology Systems Center (PTSC), NIH All of Us Research Program, a landmark program to recruit, engage and provide data insights to a nationwide cohort of 1+ million Americans. Mr. Jain brings deep experience in government, academia and industry public-private partnerships and formed, led and managed large consortiums to deliver large multi-year projects and mitigate risks. Mr. Jain has architected, defined, and led the development and commercialization of participant and patient-centered digital platforms for clinical trials, precision medicine research and digital therapeutics
heading
David R. Penberthy, MD
Associate Professor of Radiation Oncology, Penn State Health | President, Association of Community Cancer Centers 2022-2023
Medical doctor, board certified Radiation Oncologist. Experienced with a variety of technologically sophisticated treatments including Gamma Knife and linear accelerator based radiosurgery, brachytherapy, external beam radiotherapy, and radiopharmaceuticals. Former Partner and past President, Virginia Radiation Oncology Associates, Inc. Currently Medical Director of Radiation Oncology, Bon Secours Southside Medical Center. Immediate past Chairman, Board of Trustees, Bon Secours Southside Medical Center. President, ACCC Board of Trustees 2022-2023 term.
heading
Lekan Ajayi, MBA, PharmD
COO, Highland Oncology Group | Secretary, Association of Community Cancer Centers
As the chief operating officer at Highlands Oncology Group, Olalekan “Lekan” Ajayi is responsible for the regional operations of the company. He brings more than 12 years of experience to Highlands Oncology. His experience and leadership have been focused on operational excellence and developing processes that provide outstanding patient care and drive sustainable growth.
heading
Premal Thaker, MD, MS
Director of Gynecological Oncology Clinical Research Division of Gynecologic Oncology, Washington University School of Medicine
As a member of our ovarian, cervical and endometrial cancer specialist teams, Dr. Thaker cares for patients diagnosed with these cancers through treatment and recovery. Dr. Thanker's research interests include biobehavioral influences on cancer development and therapy in gynecologic malignancies.
heading
Nadine J. Barrett, PhD., MA., MS.
Founding Director, Center for Equity in Research, Duke Clinical and Translational Science Institute | Co-Director, CTSI, Equity, Community and Stakeholder Strategy | Associate Director, Equity, Community and Stakeholder Strategy, Duke Cancer Institute
A medical sociologist by training, Dr. Barrett is a health disparities researcher, expert equity strategist, and a nationally-recognized leader in facilitating community/stakeholder and academic partnerships to advance health equity. She develops training and innovative methods to address implicit bias and structural and systemic racism that limits diverse participation in biomedical research and access to care.
Become a participant in the Community Oncology Registry (CORe)